Home » Healthcare » Canada Gastrointestinal Products Market

Canada Gastrointestinal Products Market By Devices (Endoscopy Devices, Ablation Devices, Motility Testing Devices, Biopsy Devices, Stenting Devices); By Indications (Gastrointestinal Cancers, Gastroesophageal Reflux Disease, Irritable Bowel Syndrome, Inflammatory Bowel Disease, Other Diseases); By End-User (Hospitals, Ambulatory Surgical Centers & Independent Surgical Centers, Clinics, Other End Users) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2019-2022
Base Year	2023
Forecast Period	2024-2032
Canada Gastrointestinal Products Market Size 2023	USD 468.40 million
Canada Gastrointestinal Products Market, CAGR	5.43%
Canada Gastrointestinal Products Market Size 2032	USD 753.79 million

Market Overview

The Canada gastrointestinal Products Market is projected to grow from USD 468.40 million in 2023 to USD 753.79 million by 2032, reflecting a compound annual growth rate (CAGR) of 5.43%.

The Canada gastrointestinal products market is driven by the rising prevalence of gastrointestinal disorders, such as irritable bowel syndrome (IBS) and Crohn’s disease, fueled by an aging population and changing dietary habits. Increasing awareness of digestive health and the growing demand for over-the-counter products also contribute to market growth. Technological advancements in diagnostics and treatment methods, such as biologics and personalized therapies, further enhance the market’s potential. Additionally, the shift toward natural and organic products is gaining momentum as consumers seek safer alternatives to traditional medications. Moreover, the expansion of healthcare infrastructure and the increasing availability of gastrointestinal products through online platforms are supporting market accessibility and growth.

The geographical landscape of Canada’s gastrointestinal products market reflects diverse growth patterns across regions, driven by variations in healthcare infrastructure and population demographics. Ontario and Quebec are pivotal regions due to their advanced medical facilities and high prevalence of gastrointestinal conditions, fostering significant demand for diagnostic and therapeutic products. Western Canada and British Columbia are emerging areas of growth, supported by increasing healthcare investments and rising awareness about digestive health. Key players in the Canadian market include prominent multinational companies such as Ethicon Endo-Surgery, Medtronic, and Smith & Nephew, as well as regionally influential firms like Karl Storz and Hoya. These companies focus on innovative product development, strategic partnerships, and technological advancements to meet the growing demand for effective gastrointestinal solutions. The competitive landscape is further shaped by the presence of both established brands and new entrants, driving the market’s evolution through a mix of innovation and strategic expansions.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Market Insights

The Canada gastrointestinal products market was valued at USD 468.40 million in 2023 and is expected to grow at a CAGR of 5.43%, reaching USD 753.79 million by 2032.
Increasing prevalence of gastrointestinal disorders like GERD, IBD, and IBS is a major driver of market growth.
Rising adoption of minimally invasive diagnostic tools, such as endoscopy devices, is boosting demand for advanced medical technologies.
Growing consumer awareness of gut health and the demand for OTC digestive products, including probiotics, are shaping market trends.
Key players like Medtronic, Ethicon Endo-Surgery, and Smith & Nephew are focusing on innovation and strategic collaborations to strengthen their market position.
High costs of advanced diagnostic and therapeutic devices and limited healthcare access in remote areas are key restraints.
Ontario and Quebec lead the market, while Western Canada and British Columbia exhibit emerging growth potential due to increasing healthcare investments.

Market Drivers

Increasing Prevalence of Gastrointestinal Disorders

The rising incidence of gastrointestinal disorders, such as irritable bowel syndrome (IBS), Crohn’s disease, and acid reflux, is a major driver of the Canada gastrointestinal products market. As the population ages and lifestyle factors such as poor diet and high-stress levels continue to affect digestive health, the demand for treatment solutions is growing. For instance, a report by Crohn’s and Colitis Canada noted that over 320,000 Canadians are living with inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis. The need for effective gastrointestinal products to manage and alleviate symptoms has led to an increased market focus on therapies for chronic digestive conditions, further driving growth in this sector.

Growing Awareness of Digestive Health

There is a significant rise in public awareness regarding digestive health, with consumers becoming more proactive in managing gastrointestinal conditions. Educational campaigns and increased media coverage have highlighted the importance of maintaining gut health, influencing consumer behavior. For instance, the Canadian Digestive Health Foundation has been actively promoting awareness through various initiatives and campaigns, emphasizing the importance of gut health. This growing awareness has resulted in a higher demand for gastrointestinal products, both prescription and over-the-counter. As consumers become more informed, they are increasingly seeking products that address a wide range of digestive health issues, contributing to market expansion.

Technological Advancements in Treatment Options

Technological innovations in the diagnosis and treatment of gastrointestinal disorders are playing a key role in shaping the market. The introduction of biologic therapies, which offer targeted treatments for conditions like Crohn’s disease, has significantly enhanced treatment efficacy. Additionally, advancements in diagnostic tools, such as endoscopy and non-invasive tests, allow for earlier and more accurate detection of gastrointestinal issues. These innovations have expanded the range of available treatments, fostering the growth of the market by meeting the diverse needs of patients.

Rising Demand for Natural and Organic Products

Consumers are increasingly seeking natural and organic alternatives to traditional medications, a trend that is driving growth in the gastrointestinal products market. There is a growing preference for herbal supplements, probiotics, and other natural treatments that promote digestive health without the side effects of conventional drugs. This shift toward natural products has influenced both the development and marketing strategies of companies, leading to a more diverse range of gastrointestinal solutions in the market. As this trend continues, the demand for organic and natural digestive health products is expected to rise.

Market Trends

Rising Demand for Over-the-Counter Products

The increasing availability and consumer preference for over-the-counter (OTC) gastrointestinal products is a significant trend in Canada. With more individuals seeking convenient and accessible treatment options for digestive issues, the demand for OTC medications, such as antacids, probiotics, and fiber supplements, is rising. This trend is driven by the growing awareness of digestive health and the desire for self-management of mild to moderate gastrointestinal symptoms. As a result, pharmaceutical companies are focusing on developing and marketing OTC products that cater to these needs, thus contributing to the market’s expansion.

Growing Interest in Probiotics and Digestive Supplements

Consumers are increasingly turning to probiotics and other digestive supplements to promote gut health and alleviate gastrointestinal issues. This trend is particularly noticeable among health-conscious individuals who are seeking preventive measures rather than relying solely on traditional medications. Probiotics, in particular, have gained popularity for their ability to balance gut microbiota and improve digestive function. For instance, the International Probiotics Association reports a significant increase in the consumption of probiotic supplements in Canada, driven by their perceived benefits for gut health. As the understanding of the gut-brain connection grows, the demand for probiotics and other related supplements is expected to continue rising, further fueling the market for gastrointestinal products in Canada.

Shift Towards Personalized and Biologic Therapies

Personalized medicine is becoming a key trend in the gastrointestinal products market, with more patients opting for biologic treatments tailored to their specific conditions. Advances in biologics, such as monoclonal antibodies and targeted therapies, are revolutionizing the treatment of chronic gastrointestinal diseases like Crohn’s disease and ulcerative colitis. These therapies offer more effective and individualized treatment options, resulting in better patient outcomes. As the prevalence of such conditions increases, the demand for these advanced therapies is expected to drive market growth, alongside improvements in diagnostic technologies that enable more precise treatment.

Focus on Natural and Organic Products

Another notable trend is the growing preference for natural and organic gastrointestinal products. As consumers become more health-conscious and mindful of the ingredients in their medications, the demand for natural, plant-based, and organic alternatives is rising. This includes herbal supplements, prebiotics, and dietary products that promote digestive health without synthetic additives or chemicals. For instance, a report by the Canada Organic Trade Association highlights the increasing demand for organic and natural health products among Canadians, driven by their preference for clean and eco-friendly options. Companies are responding by diversifying their product offerings to meet the increasing demand for natural gastrointestinal solutions, further contributing to the expansion of the market in Canada.

Market Challenges Analysis

Regulatory Challenges and Product Approvals

One of the major challenges faced by the gastrointestinal products market in Canada is the stringent regulatory environment surrounding product approvals. The Canadian regulatory bodies, such as Health Canada, impose rigorous requirements for safety, efficacy, and quality before new products can be introduced to the market. This process can be time-consuming and costly, especially for new treatments or over-the-counter products. For instance, Health Canada mandates comprehensive clinical trials and detailed safety evaluations for new gastrointestinal products, which can extend approval timelines. Additionally, the need for ongoing clinical trials to ensure long-term safety adds to the financial burden for companies. These regulatory hurdles can delay the introduction of innovative products and limit the market’s ability to rapidly respond to emerging consumer needs, thereby impacting overall market growth.

Intense Market Competition and Price Sensitivity

The Canadian gastrointestinal products market is highly competitive, with a wide array of both branded and generic products available. This intense competition often leads to price sensitivity among consumers, who may opt for lower-cost options, especially for common conditions such as acid reflux or mild indigestion. Pharmaceutical companies and manufacturers must balance the need for competitive pricing with maintaining product quality and innovation. As a result, companies are under pressure to optimize manufacturing costs, streamline their supply chains, and explore pricing strategies that can help them retain market share. Furthermore, the increasing popularity of natural and homeopathic remedies presents additional competition to traditional pharmaceutical products, further challenging companies to differentiate their offerings.

Market Opportunities

Expanding OTC Product Segment

One of the key market opportunities in Canada’s gastrointestinal products sector lies in the growing demand for over-the-counter (OTC) treatments. With an increasing number of consumers preferring self-management for mild to moderate gastrointestinal issues, there is significant potential for growth in the OTC market. Products such as antacids, probiotics, fiber supplements, and digestive enzymes are becoming first-line solutions for many individuals. As healthcare awareness improves and consumers seek more accessible treatments, pharmaceutical companies can capitalize on this trend by expanding their OTC offerings. Additionally, the convenience of online platforms for purchasing gastrointestinal products further enhances market accessibility, opening new avenues for growth in both urban and rural areas across Canada.

Rising Demand for Probiotics and Natural Solutions

The growing consumer shift toward natural and organic products presents a significant opportunity in the Canadian gastrointestinal products market. Probiotics, prebiotics, and other digestive health supplements are gaining popularity as consumers increasingly seek natural alternatives to pharmaceutical treatments. As awareness of gut health’s role in overall well-being expands, the demand for these products is expected to rise. Companies that focus on developing high-quality, natural gastrointestinal products that promote digestive balance and improve overall gut health are well-positioned to capture this growing market. By leveraging this trend, manufacturers can attract health-conscious consumers looking for safe, non-synthetic treatments, offering long-term growth potential in a competitive market.

Market Segmentation Analysis:

By Devices:

The Canada gastrointestinal products market is segmented by devices, with notable categories including endoscopy devices, ablation devices, motility testing devices, biopsy devices, and stenting devices. Endoscopy devices dominate the market due to their critical role in diagnosing and monitoring various gastrointestinal disorders. These devices enable minimally invasive procedures, providing accurate insights into conditions like gastrointestinal cancers, GERD, and inflammatory bowel disease (IBD). Ablation devices are gaining traction for their use in treating specific cancers and precancerous conditions, providing targeted treatments with minimal side effects. Motility testing devices, essential for diagnosing motility disorders such as IBS, are also expanding, driven by the increasing prevalence of such conditions. Biopsy and stenting devices are witnessing growth, with stenting devices playing a crucial role in managing gastrointestinal cancers and other obstructive disorders. As the demand for advanced diagnostic and therapeutic solutions increases, these devices are expected to continue driving market expansion.

By Indications:

The Canada gastrointestinal products market is also segmented based on indications, with gastrointestinal cancers, gastroesophageal reflux disease (GERD), irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and other diseases driving demand. Gastrointestinal cancers are a significant driver due to the increasing incidence of conditions such as colorectal and esophageal cancers, pushing demand for diagnostic and treatment devices. GERD, a common disorder affecting a large portion of the Canadian population, fuels the market for related devices, such as endoscopes and ablation tools. IBS and IBD are also contributing to market growth, with a rising number of cases and a greater focus on early diagnosis and personalized treatments. Additionally, other gastrointestinal diseases, including celiac disease and peptic ulcers, continue to drive the demand for therapeutic devices and solutions. As awareness of these conditions increases and the need for more effective treatment options rises, the market is poised to expand across these various indications.

Segments:

Based on Devices:

Endoscopy Devices
Ablation Devices
Motility Testing Devices
Biopsy Devices
Stenting Devices

Based on Indications:

Gastrointestinal Cancers
Gastroesophageal Reflux Disease
Irritable Bowel Syndrome
Inflammatory Bowel Disease
Other Diseases

Based on End-User:

Hospitals
Ambulatory Surgical Centers & Independent Surgical Centers
Clinics
Other End Users

Based on the Geography:

Ontario
Quebec
Western Canada
British Columbia
Atlantic Canada

Regional Analysis

Ontario

Ontario holds the largest market share in Canada’s gastrointestinal products sector, accounting for approximately 38% of the total market. This dominance is attributed to the province’s large population, well-developed healthcare infrastructure, and high healthcare spending. Major urban centers like Toronto are hubs for medical research and healthcare services, ensuring access to advanced gastrointestinal treatments. The prevalence of gastrointestinal disorders such as gastroesophageal reflux disease (GERD), inflammatory bowel disease (IBD), and irritable bowel syndrome (IBS) is significant in Ontario, driving the demand for diagnostic and therapeutic products. Given its substantial healthcare investments, Ontario is expected to continue leading the market, maintaining its dominant share in the coming years.

Quebec

Quebec holds the second-largest market share in the Canadian gastrointestinal products market, accounting for around 26% of the total revenue. The province’s healthcare system is robust and well-funded, providing widespread access to gastrointestinal treatments and devices. The rising prevalence of digestive health conditions and a growing public awareness of gastrointestinal disorders are key factors fueling demand. Quebec is also investing in healthcare technology, which contributes to the availability of advanced products like endoscopy and biopsy devices. The demand for effective treatment solutions is anticipated to rise, with Quebec’s market share expected to grow as the population ages and more people seek gastrointestinal health management.

Western Canada

Western Canada, which includes provinces such as Alberta, Saskatchewan, and Manitoba, holds a combined market share of approximately 20%. Although it has a smaller population than Ontario and Quebec, the region’s growing healthcare infrastructure and increased awareness of gastrointestinal health are driving demand for diagnostic and therapeutic devices. With higher rates of gastrointestinal diseases such as IBS and Crohn’s disease, the region presents significant growth opportunities. Investments in healthcare facilities and expanding access to medical technologies will likely increase the market share in Western Canada, with this segment expected to show steady growth in the coming years.

Atlantic Canada

Atlantic Canada, encompassing Nova Scotia, New Brunswick, Prince Edward Island, and Newfoundland and Labrador, holds a smaller market share of around 16%. However, the region offers emerging growth potential. The smaller population and lower healthcare spending compared to other provinces contribute to its reduced market share. Nevertheless, increasing healthcare investments, an aging population, and rising awareness of gastrointestinal health are likely to drive future growth. As more advanced gastrointestinal treatments become available and access to healthcare improves, Atlantic Canada is expected to experience gradual growth in its market share, representing a promising opportunity for expansion in the gastrointestinal products sector.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key Player Analysis

Instrumed Surgical Holdings Corporation
Instrumed Surgical Holdings
Instrumed Surgical
Ethicon Endo-Surgery
Medtronic
Stryker
Smith & Nephew
Karl Storz
Hoya
Company 10
Company 11
Company 12
Company 13
Company 14

Competitive Analysis

The competitive landscape of Canada’s gastrointestinal products market is characterized by the presence of established global players and regionally influential companies. Leading players, including Medtronic, Ethicon Endo-Surgery, Smith & Nephew, Karl Storz, and Hoya, are driving the market through innovation, strategic collaborations, and extensive product portfolios. These companies focus on the development of advanced diagnostic and therapeutic solutions, such as endoscopy devices, ablation tools, and biopsy instruments, catering to the growing demand for minimally invasive procedures. The competition is further intensified by the emphasis on research and development, which enables companies to introduce technologically advanced products that address a wide range of gastrointestinal disorders. Strategic partnerships and acquisitions are also prevalent strategies to expand market reach and strengthen footholds in the Canadian market. For example, collaborations with healthcare providers ensure better distribution channels and enhanced accessibility to products. Additionally, players invest in marketing and educational initiatives to increase awareness of gastrointestinal health, fostering product adoption. For instance, the growing demand for probiotics and prebiotics in Canada presents a significant opportunity for new entrants to cater to health-conscious consumers. Despite strong competition, the market offers opportunities for new entrants and smaller companies to gain a foothold by focusing on niche segments, such as probiotics or motility testing devices. Overall, the competitive dynamics encourage innovation and drive the growth of the gastrointestinal products market in Canada.

Recent Developments

In April 2023, Boston Scientific announced the launch of the EXALT Model B Single-use Bronchoscope, which expands its single-use endoscopy portfolio. This device is designed for diagnostic and therapeutic bronchoscopy procedures and offers high-resolution imaging and precise control.
In March 2023, Polifarma Spa expanded its gastrointestinal portfolio through a long-term distribution agreement with Devintec Pharma Sagl, a Lugano-based company known for pioneering substance-based medical devices and the Gelsectan brand.
In April 2023, Italian pharmaceutical innovator Azienda Farmaceutica Italiana partnered with TannerLAC, Inc. to distribute Hepilor, a medical device designed to protect the digestive system mucosa, throughout Latin America.
In May 2022, Dr. Reddy’s Laboratories Ltd. announced a partnership with South Korea’s HK inno.N Corporation to supply and commercialize HK inno.N’s patented novel molecule, Tegoprazan, for treating gastrointestinal diseases in India and six key emerging markets.
In March 2022, AbbVie Inc. received U.S. FDA approval for its novel drug, RINVOQ (upadacitinib), for the treatment of moderately to severely active ulcerative colitis.

Market Concentration & Characteristics

The Canada gastrointestinal products market exhibits moderate market concentration, with a mix of established global players and emerging regional companies competing for market share. Prominent multinational corporations such as Medtronic, Ethicon Endo-Surgery, Smith & Nephew, Karl Storz, and Hoya dominate the market, leveraging their extensive product portfolios, advanced technologies, and robust distribution networks. These companies focus on innovation and R&D to introduce minimally invasive diagnostic and therapeutic solutions, aligning with the growing demand for efficient gastrointestinal treatments. The market is characterized by its dynamic nature, driven by advancements in medical technologies, rising healthcare expenditures, and increasing awareness about digestive health. Companies adopt diverse strategies, including mergers, acquisitions, and collaborations, to expand their presence and enhance product accessibility. Simultaneously, regional players are gaining traction by targeting niche segments such as motility testing devices and probiotics.

The industry faces challenges such as high costs associated with advanced products and uneven healthcare access in remote areas, which create entry barriers for smaller players. However, the increasing prevalence of gastrointestinal disorders and the growing adoption of innovative solutions offer significant opportunities for market expansion. As a result, the market remains competitive yet ripe for innovation and strategic growth across various segments.

Report Coverage

The research report offers an in-depth analysis based on Devices, Indications, End-User and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The Canada gastrointestinal products market is expected to witness steady growth driven by increasing prevalence of gastrointestinal disorders.
Advancements in minimally invasive technologies are likely to shape future product development and adoption.
Rising consumer awareness about digestive health is expected to drive demand for OTC products like probiotics and antacids.
Key players are anticipated to focus on R&D investments to introduce innovative diagnostic and therapeutic solutions.
Strategic collaborations between healthcare providers and manufacturers will enhance product accessibility and distribution.
The aging population in Canada will likely contribute to an increased need for gastrointestinal treatments.
Regional markets such as Western Canada and British Columbia are expected to exhibit significant growth potential.
Cost-effective solutions and local production are expected to aid smaller players in capturing niche segments.
Integration of AI and digital technologies in diagnostics may offer advanced insights and faster treatments.
The market is expected to remain competitive, fostering innovation and diversification among industry leaders.

CHAPTER NO. 1 : INTRODUCTION 20

1.1.1. Report Description 20

Purpose of the Report 20

USP & Key Offerings 20

1.1.2. Key Benefits for Stakeholders 20

1.1.3. Target Audience 21

1.1.4. Report Scope 21

CHAPTER NO. 2 : EXECUTIVE SUMMARY 22

2.1. GASTROINTESTINAL PRODUCTS Market Snapshot 22

2.1.1. Canada GASTROINTESTINAL PRODUCTS Market, 2018 – 2032 (USD Million) 23

CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS 24

3.1. Russia-Ukraine and Israel-Palestine War Impacts 24

CHAPTER NO. 4 : GASTROINTESTINAL PRODUCTS MARKET – INDUSTRY ANALYSIS 25

4.1. Introduction 25

4.2. Market Drivers 26

4.2.1. GI Disorders on a Rise 26

4.2.2. New and innovative technologies driving the market 27

4.3. Market Restraints 28

4.3.1. Stringent Regulations 28

4.4. Market Opportunities 29

4.4.1. Market Opportunity Analysis 29

4.5. Porter’s Five Forces Analysis 30

4.6. Value Chain Analysis 31

4.7. Buying Criteria 32

CHAPTER NO. 5 : IMPORT EXPORT ANALYSIS 33

5.1. Import Analysis by Canada 33

5.1.1. Canada GASTROINTESTINAL PRODUCTS Market Import Volume/Revenue, By Canada, 2018 – 2023 33

5.2. Export Analysis by Canada 34

5.2.1. Canada GASTROINTESTINAL PRODUCTS Market Export Volume/Revenue, By Canada, 2018 – 2023 34

CHAPTER NO. 6 : DEMAND SUPPLY ANALYSIS 35

6.1. Demand Analysis by Canada 35

6.1.1. Canada GASTROINTESTINAL PRODUCTS Market Demand Volume/Revenue, By Canada, 2018 – 2023 35

6.2. Supply Analysis by Canada 36

6.2.1. Canada GASTROINTESTINAL PRODUCTS Market Supply Volume/Revenue, By Canada, 2018 – 2023 36

CHAPTER NO. 7 : PRODUCTION ANALYSIS 37

7.1. Production Analysis by Canada 37

7.1.1. Canada GASTROINTESTINAL PRODUCTS Market Production Volume/Revenue, By Canada, 2018 – 2023 37

CHAPTER NO. 8 : PRICE ANALYSIS 38

8.1. Price Analysis by Devices 38

8.1.1. Canada GASTROINTESTINAL PRODUCTS Market Price, By Devices, 2018 – 2023 38

8.1.2. Canada Devices Market Price, By Devices, 2018 – 2023 38

CHAPTER NO. 9 : RAW MATERIALS ANALYSIS 39

9.1. Key Raw Materials and Suppliers 39

9.2. Key Raw Materials Price Trend 39

CHAPTER NO. 10 : MANUFACTURING COST ANALYSIS 40

10.1. Manufacturing Cost Analysis 40

10.2. Manufacturing Process 40

CHAPTER NO. 11 : ANALYSIS COMPETITIVE LANDSCAPE 41

11.1. Company Market Share Analysis – 2023 41

11.1.1. Canada GASTROINTESTINAL PRODUCTS Market: Company Market Share, by Volume, 2023 41

11.1.2. Canada GASTROINTESTINAL PRODUCTS Market: Company Market Share, by Revenue, 2023 42

11.1.3. Canada GASTROINTESTINAL PRODUCTS Market: Top 6 Company Market Share, by Revenue, 2023 42

11.1.4. Canada GASTROINTESTINAL PRODUCTS Market: Top 3 Company Market Share, by Revenue, 2023 43

11.2. Canada GASTROINTESTINAL PRODUCTS Market Company Volume Market Share, 2023 44

11.3. Canada GASTROINTESTINAL PRODUCTS Market Company Revenue Market Share, 2023 45

11.4. Company Assessment Metrics, 2023 46

11.4.1. Stars 46

11.4.2. Emerging Leaders 46

11.4.3. Pervasive Players 46

11.4.4. Participants 46

11.5. Start-ups /SMEs Assessment Metrics, 2023 46

11.5.1. Progressive Companies 46

11.5.2. Responsive Companies 46

11.5.3. Dynamic Companies 46

11.5.4. Starting Blocks 46

11.6. Strategic Developments 47

11.6.1. Acquisitions & Mergers 47

New Product Launch 47

Canada Expansion 47

11.7. Key Players Product Matrix 48

CHAPTER NO. 12 : PESTEL & ADJACENT MARKET ANALYSIS 49

12.1. PESTEL 49

12.1.1. Political Factors 49

12.1.2. Economic Factors 49

12.1.3. Social Factors 49

12.1.4. Technological Factors 49

12.1.5. Environmental Factors 49

12.1.6. Legal Factors 49

12.2. Adjacent Market Analysis 49

CHAPTER NO. 13 : GASTROINTESTINAL PRODUCTS MARKET – BY DEVICES SEGMENT ANALYSIS 50

13.1. GASTROINTESTINAL PRODUCTS Market Overview, by Devices Segment 50

13.1.1. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Devices, 2023 & 2032 51

13.1.2. GASTROINTESTINAL PRODUCTS Market Attractiveness Analysis, By Devices 52

13.1.3. Incremental Revenue Growth Opportunity, by Devices, 2024 – 2032 52

13.1.4. GASTROINTESTINAL PRODUCTS Market Revenue, By Devices, 2018, 2023, 2027 & 2032 53

13.2. Endoscopy Devices 54

13.3. Ablation Devices 55

13.4. Motility Testing Devices 56

13.5. Biospy Devices 57

13.6. Stenting Devices 58

CHAPTER NO. 14 : GASTROINTESTINAL PRODUCTS MARKET – BY INDICATIONS SEGMENT ANALYSIS 59

14.1. GASTROINTESTINAL PRODUCTS Market Overview, by Indications Segment 59

14.1.1. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Indications, 2023 & 2032 60

14.1.2. GASTROINTESTINAL PRODUCTS Market Attractiveness Analysis, By Indications 61

14.1.3. Incremental Revenue Growth Opportunity, by Indications, 2024 – 2032 61

14.1.4. GASTROINTESTINAL PRODUCTS Market Revenue, By Indications, 2018, 2023, 2027 & 2032 62

14.2. Gastrointestinal Cancers 63

14.3. Gastroesophageal Reflux Disease 64

14.4. Irritable Bowl Syndrome 65

14.5. Inflammatory Bowel Disease 66

14.6. Other Disease 67

CHAPTER NO. 15 : GASTROINTESTINAL PRODUCTS MARKET – BY END-USER SEGMENT ANALYSIS 68

15.1. GASTROINTESTINAL PRODUCTS Market Overview, by End-user Segment 68

15.1.1. GASTROINTESTINAL PRODUCTS Market Revenue Share, By End-user, 2023 & 2032 69

15.1.2. GASTROINTESTINAL PRODUCTS Market Attractiveness Analysis, By End-user 70

15.1.3. Incremental Revenue Growth Opportunity, by End-user, 2024 – 2032 70

15.1.4. GASTROINTESTINAL PRODUCTS Market Revenue, By End-user, 2018, 2023, 2027 & 2032 71

15.2. Hospital 72

15.3. Ambulatory Surgical Center & Independent Surgical Center 73

15.4. Clinics 74

15.5. Other End Users 75

CHAPTER NO. 16 : COMPANY PROFILES 76

16.1. Instrumed Surgical Holdings Corporation 76

16.1.1. Company Overview 76

16.1.2. Product Portfolio 76

16.1.3. Swot Analysis 76

16.1.4. Business Strategy 77

16.1.5. Financial Overview 77

16.2. Instrumed Surgical Holdings 78

16.3. Instrumed Surgical 78

16.4. Ethicon Endo-Surgery 78

16.5. Medtronic 78

16.6. Stryker 78

16.7. Smith & Nephew 78

16.8. Karl Storz 78

16.9. Hoya 78

16.10. Company 10 78

16.11. Company 11 78

16.12. Company 12 78

16.13. Company 13 78

16.14. Company 14 78

List of Figures

FIG NO. 1. Canada GASTROINTESTINAL PRODUCTS Market Revenue, 2018 – 2032 (USD Million) 22

FIG NO. 2. Porter’s Five Forces Analysis for Canada GASTROINTESTINAL PRODUCTS Market 29

FIG NO. 3. Value Chain Analysis for Canada GASTROINTESTINAL PRODUCTS Market 30

FIG NO. 4. Canada GASTROINTESTINAL PRODUCTS Market Import Volume/Revenue, By Canada, 2018 – 2023 32

FIG NO. 5. Canada GASTROINTESTINAL PRODUCTS Market Export Volume/Revenue, By Canada, 2018 – 2023 33

FIG NO. 6. Canada GASTROINTESTINAL PRODUCTS Market Demand Volume/Revenue, By Canada, 2018 – 2023 34

FIG NO. 7. Canada GASTROINTESTINAL PRODUCTS Market Supply Volume/Revenue, By Canada, 2018 – 2023 35

FIG NO. 8. Canada GASTROINTESTINAL PRODUCTS Market Production Volume/Revenue, By Canada, 2018 – 2023 36

FIG NO. 9. Canada GASTROINTESTINAL PRODUCTS Market Price, By Devices, 2018 – 2023 37

FIG NO. 10. Raw Materials Price Trend Analysis, 2018 – 2023 38

FIG NO. 11. Manufacturing Cost Analysis 39

FIG NO. 12. Manufacturing Process 39

FIG NO. 13. Company Share Analysis, 2023 40

FIG NO. 14. Company Share Analysis, 2023 41

FIG NO. 15. Company Share Analysis, 2023 41

FIG NO. 16. Company Share Analysis, 2023 42

FIG NO. 17. GASTROINTESTINAL PRODUCTS Market – Company Volume Market Share, 2023 43

FIG NO. 18. GASTROINTESTINAL PRODUCTS Market – Company Revenue Market Share, 2023 44

FIG NO. 19. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Devices, 2023 & 2032 50

FIG NO. 20. Market Attractiveness Analysis, By Devices 51

FIG NO. 21. Incremental Revenue Growth Opportunity by Devices, 2024 – 2032 51

FIG NO. 22. GASTROINTESTINAL PRODUCTS Market Revenue, By Devices, 2018, 2023, 2027 & 2032 52

FIG NO. 23. Canada GASTROINTESTINAL PRODUCTS Market for Endoscopy Devices, Revenue (USD Million) 2018 – 2032 53

FIG NO. 24. Canada GASTROINTESTINAL PRODUCTS Market for Ablation Devices, Revenue (USD Million) 2018 – 2032 54

FIG NO. 25. Canada GASTROINTESTINAL PRODUCTS Market for Motility Testing Devices, Revenue (USD Million) 2018 – 2032 55

FIG NO. 26. Canada GASTROINTESTINAL PRODUCTS Market for Biospy Devices, Revenue (USD Million) 2018 – 2032 56

FIG NO. 27. Canada GASTROINTESTINAL PRODUCTS Market for Stenting Devices, Revenue (USD Million) 2018 – 2032 57

FIG NO. 28. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Indications, 2023 & 2032 59

FIG NO. 29. Market Attractiveness Analysis, By Indications 60

FIG NO. 30. Incremental Revenue Growth Opportunity by Indications, 2024 – 2032 60

FIG NO. 31. GASTROINTESTINAL PRODUCTS Market Revenue, By Indications, 2018, 2023, 2027 & 2032 61

FIG NO. 32. Canada GASTROINTESTINAL PRODUCTS Market for Gastrointestinal Cancers, Revenue (USD Million) 2018 – 2032 62

FIG NO. 33. Canada GASTROINTESTINAL PRODUCTS Market for Gastroesophageal Reflux Disease, Revenue (USD Million) 2018 – 2032 63

FIG NO. 34. Canada GASTROINTESTINAL PRODUCTS Market for Irritable Bowl Syndrome, Revenue (USD Million) 2018 – 2032 64

FIG NO. 35. Canada GASTROINTESTINAL PRODUCTS Market for Inflammatory Bowel Disease, Revenue (USD Million) 2018 – 2032 65

FIG NO. 36. Canada GASTROINTESTINAL PRODUCTS Market for Other Disease, Revenue (USD Million) 2018 – 2032 66

FIG NO. 37. GASTROINTESTINAL PRODUCTS Market Revenue Share, By End-user, 2023 & 2032 68

FIG NO. 38. Market Attractiveness Analysis, By End-user 69

FIG NO. 39. Incremental Revenue Growth Opportunity by End-user, 2024 – 2032 69

FIG NO. 40. GASTROINTESTINAL PRODUCTS Market Revenue, By End-user, 2018, 2023, 2027 & 2032 70

FIG NO. 41. Canada GASTROINTESTINAL PRODUCTS Market for Hospital, Revenue (USD Million) 2018 – 2032 71

FIG NO. 42. Canada GASTROINTESTINAL PRODUCTS Market for Ambulatory Surgical Center & Independent Surgical Center, Revenue (USD Million) 2018 – 2032 72

FIG NO. 43. Canada GASTROINTESTINAL PRODUCTS Market for Clinics, Revenue (USD Million) 2018 – 2032 73

FIG NO. 44. Canada GASTROINTESTINAL PRODUCTS Market for Other End Users, Revenue (USD Million) 2018 – 2032 74

FIG NO. 45. Canada GASTROINTESTINAL PRODUCTS Market for End-user 5, Revenue (USD Million) 2018 – 2032 75

FIG NO. 46. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Technology, 2023 & 2032 77

FIG NO. 47. Market Attractiveness Analysis, By Technology 78

FIG NO. 48. Incremental Revenue Growth Opportunity by Technology, 2024 – 2032 78

FIG NO. 49. GASTROINTESTINAL PRODUCTS Market Revenue, By Technology, 2018, 2023, 2027 & 2032 79

FIG NO. 50. Canada GASTROINTESTINAL PRODUCTS Market for Technology 1, Revenue (USD Million) 2018 – 2032 80

FIG NO. 51. Canada GASTROINTESTINAL PRODUCTS Market for Technology 2, Revenue (USD Million) 2018 – 2032 81

FIG NO. 52. Canada GASTROINTESTINAL PRODUCTS Market for Technology 3, Revenue (USD Million) 2018 – 2032 82

FIG NO. 53. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Distribution Channel, 2023 & 2032 84

FIG NO. 54. Market Attractiveness Analysis, By Distribution Channel 85

FIG NO. 55. Incremental Revenue Growth Opportunity by Distribution Channel, 2024 – 2032 85

FIG NO. 56. GASTROINTESTINAL PRODUCTS Market Revenue, By Distribution Channel, 2018, 2023, 2027 & 2032 86

FIG NO. 57. Canada GASTROINTESTINAL PRODUCTS Market for Distribution Channel 1, Revenue (USD Million) 2018 – 2032 87

FIG NO. 58. Canada GASTROINTESTINAL PRODUCTS Market for Distribution Channel 2, Revenue (USD Million) 2018 – 2032 88

FIG NO. 59. Canada GASTROINTESTINAL PRODUCTS Market for Distribution Channel 3, Revenue (USD Million) 2018 – 2032 89

FIG NO. 60. Canada GASTROINTESTINAL PRODUCTS Market for Distribution Channel 4, Revenue (USD Million) 2018 – 2032 90

FIG NO. 61. Canada GASTROINTESTINAL PRODUCTS Market for Distribution Channel 5, Revenue (USD Million) 2018 – 2032 91

FIG NO. 62. Research Methodology – Detailed View 100

FIG NO. 63. Research Methodology 101

List of Tables

TABLE NO. 1. : Canada GASTROINTESTINAL PRODUCTS Market: Snapshot 18

TABLE NO. 2. : Drivers for the GASTROINTESTINAL PRODUCTS Market: Impact Analysis 22

TABLE NO. 3. : Restraints for the GASTROINTESTINAL PRODUCTS Market: Impact Analysis 24

TABLE NO. 4. : Canada GASTROINTESTINAL PRODUCTS Market Revenue, By Devices, 2018 – 2023 34

TABLE NO. 5. : Key Raw Materials & Suppliers 35

TABLE NO. 6. : Canada GASTROINTESTINAL PRODUCTS Market Revenue, By Devices, 2018 – 2023 (USD Million) 89

TABLE NO. 7. : Canada GASTROINTESTINAL PRODUCTS Market Revenue, By Devices, 2024 – 2032 (USD Million) 89

TABLE NO. 8. : Canada GASTROINTESTINAL PRODUCTS Market Revenue, By Indications, 2018 – 2023 (USD Million) 90

TABLE NO. 9. : Canada GASTROINTESTINAL PRODUCTS Market Revenue, By Indications, 2024 – 2032 (USD Million) 90

TABLE NO. 10. : Canada GASTROINTESTINAL PRODUCTS Market Revenue, By End-user, 2018 – 2023 (USD Million) 91

TABLE NO. 11. : Canada GASTROINTESTINAL PRODUCTS Market Revenue, By End-user, 2024 – 2032 (USD Million) 91

TABLE NO. 12. : Canada GASTROINTESTINAL PRODUCTS Market Revenue, By Technology, 2018 – 2023 (USD Million) 92

TABLE NO. 13. : Canada GASTROINTESTINAL PRODUCTS Market Revenue, By Technology, 2024 – 2032 (USD Million) 92

TABLE NO. 14. : Canada GASTROINTESTINAL PRODUCTS Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 93

TABLE NO. 15. : Canada GASTROINTESTINAL PRODUCTS Market Revenue, By Distribution Channel, 2024 – 2032 (USD Million) 93

Frequently Asked Questions

What is the current size of the Canada Gastrointestinal Products market?

The Canada gastrointestinal products market was valued at USD 468.40 million in 2023 and is projected to reach USD 753.79 million by 2032, growing at a compound annual growth rate (CAGR) of 5.43%.

What factors are driving the growth of the Canada Gastrointestinal Products market?

The growth is driven by the rising prevalence of gastrointestinal disorders like IBS and Crohn’s disease, increasing awareness about digestive health, growing demand for OTC products like probiotics, advancements in diagnostic technologies, and a shift toward natural and organic gastrointestinal solutions.

What are the key segments within the Canada Gastrointestinal Products market?

The market is segmented by:
• Devices: Endoscopy Devices, Ablation Devices, Motility Testing Devices, Biopsy Devices, and Stenting Devices.
• Indications: Gastrointestinal Cancers, GERD, IBS, IBD, and Other Diseases.
• End-Users: Hospitals, Ambulatory Surgical Centers, Clinics, and Others.
• Geography: Ontario, Quebec, Western Canada, British Columbia, and Atlantic Canada.

Who are the major players in the Canada Gastrointestinal Products market?

Key players include Medtronic, Ethicon Endo-Surgery, Smith & Nephew, Karl Storz, Hoya, and regional firms like Instrumed Surgical Holdings. These companies focus on innovation, advanced technologies, and strategic collaborations to strengthen their market presence.

Purchase Options

Single User

$2699

Multi User

$3699

Custom Report

$5699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –